KMDA

SEC source: 0001213900-26-102824 · ownership.xml · derivative · entry 1

Beladev Shavit · CIK 0002068363 · VP Plasma Operations

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 15,000

Underlying: Ordinary Shares · 15,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F4 · derivative.exercise_price: This option was previously reported as covering 15,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102615 · ownership.xml · derivative · entry 2

Livneh Nir · CIK 0002067543 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 60,000

Underlying: Ordinary Shares · 60,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F5 · derivative.exercise_price: This option was previously reported as covering 60,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102615 · ownership.xml · derivative · entry 1

Livneh Nir · CIK 0002067543 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 29,485

Underlying: Ordinary Shares · 29,485 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F4 · derivative.exercise_price: This option was previously reported as covering 29,485 ordinary shares at an exercise price of $5.59. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102609 · ownership.xml · derivative · entry 2

Pinchuk Orit · CIK 0002068360 · VP Regulatory Affairs

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 60,000

Underlying: Ordinary Shares · 60,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F5 · derivative.exercise_price: This option was previously reported as covering 60,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102609 · ownership.xml · derivative · entry 1

Pinchuk Orit · CIK 0002068360 · VP Regulatory Affairs

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 15,000

Underlying: Ordinary Shares · 15,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F4 · derivative.exercise_price: This option was previously reported as covering 15,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102604 · ownership.xml · derivative · entry 3

RECANATI LEON · CIK 0000919590 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 30,000

Underlying: Ordinary Shares · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F6 · derivative.exercise_price: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.55. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102604 · ownership.xml · derivative · entry 2

RECANATI LEON · CIK 0000919590 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 30,000

Underlying: Ordinary Shares · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F5 · derivative.exercise_price: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102604 · ownership.xml · derivative · entry 1

RECANATI LEON · CIK 0000919590 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 26,500

Underlying: Ordinary Shares · 26,500 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F4 · derivative.exercise_price: This option was previously reported as covering 26,500 ordinary shares at an exercise price of $7.58. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102600 · ownership.xml · derivative · entry 3

ORLEV CHAIME · CIK 0001345636 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 90,000

Underlying: Ordinary Shares · 90,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F6 · derivative.exercise_price: This option was previously reported as covering 90,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102600 · ownership.xml · derivative · entry 2

ORLEV CHAIME · CIK 0001345636 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 90,000

Underlying: Ordinary Shares · 90,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F5 · derivative.exercise_price: This option was previously reported as covering 90,000 ordinary shares at an exercise price of $6.19. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102600 · ownership.xml · derivative · entry 1

ORLEV CHAIME · CIK 0001345636 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 22,500

Underlying: Ordinary Shares · 22,500 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F4 · derivative.exercise_price: This option was previously reported as covering 22,500 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102523 · ownership.xml · derivative · entry 2

Nir Eran · CIK 0002067540 · VP, Operations

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 90,000

Underlying: Ordinary Shares · 90,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F5 · derivative.exercise_price: This option was previously reported as covering 90,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102523 · ownership.xml · derivative · entry 1

Nir Eran · CIK 0002067540 · VP, Operations

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 22,500

Underlying: Ordinary Shares · 22,500 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F4 · derivative.exercise_price: This option was previously reported as covering 22,500 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102515 · ownership.xml · derivative · entry 2

ITSHAYEK ASSAF · CIK 0001481487 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 30,000

Underlying: Ordinary Shares · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F5 · derivative.exercise_price: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.55. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102515 · ownership.xml · derivative · entry 1

ITSHAYEK ASSAF · CIK 0001481487 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 16,000

Underlying: Ordinary Shares · 16,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F4 · derivative.exercise_price: This option was previously reported as covering 16,000 ordinary shares at an exercise price of $6.27. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102513 · ownership.xml · derivative · entry 2

Dekel Benjamin · CIK 0002077142 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 30,000

Underlying: Ordinary Shares · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F5 · derivative.exercise_price: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.55. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102513 · ownership.xml · derivative · entry 1

Dekel Benjamin · CIK 0002077142 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 16,000

Underlying: Ordinary Shares · 16,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F4 · derivative.exercise_price: This option was previously reported as covering 16,000 ordinary shares at an exercise price of $6.27. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102511 · ownership.xml · derivative · entry 2

Neheman Hanni · CIK 0002067611 · VP, Marketing & Sales

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 60,000

Underlying: Ordinary Shares · 60,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F5 · derivative.exercise_price: This option was previously reported as covering 60,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102511 · ownership.xml · derivative · entry 1

Neheman Hanni · CIK 0002067611 · VP, Marketing & Sales

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 15,000

Underlying: Ordinary Shares · 15,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

F4 · derivative.exercise_price: This option was previously reported as covering 15,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102367 · ownership.xml · derivative · entry 1

Brenner Yael · CIK 0002064606 · VP Quality

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 60,000

Underlying: Ordinary Shares · 60,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 22, 2026.

F4 · derivative.exercise_price: This option was previously reported as covering 60,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: Options vest in four equal installments, with 25% vested on each of the four anniversaries of the date of grant.

F2 · derivative.expiration_date: Options vest in four equal installments, with 25% vested on each of the four anniversaries of the date of grant.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102361 · ownership.xml · derivative · entry 2

Tsur David · CIK 0002069828 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 30,000

Underlying: Ordinary Shares · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 22, 2026.

F5 · derivative.exercise_price: This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.55. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date.

F2 · derivative.expiration_date: The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-102361 · ownership.xml · derivative · entry 1

Tsur David · CIK 0002069828 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 7,500

Underlying: Ordinary Shares · 7,500 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 22, 2026.

F4 · derivative.exercise_price: This option was previously reported as covering 7,500 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

F2 · derivative.exercise_date: The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date.

F2 · derivative.expiration_date: The options vested over a period of four years in four equal installments, such that 25% of the options vested on each anniversary of the grant date.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-095332 · ownership.xml · derivative · entry 9

Brenner Yael · CIK 0002064606 · VP Quality

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 0

Underlying: Ordinary Shares · 10,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 26, 2026.

F3 · derivative.exercise_date: Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant.

F3 · derivative.expiration_date: Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant.

F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-095332 · ownership.xml · derivative · entry 8

Brenner Yael · CIK 0002064606 · VP Quality

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 0

Underlying: Ordinary Shares · 10,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 26, 2026.

F3 · derivative.exercise_date: Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant.

F3 · derivative.expiration_date: Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant.

F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-095332 · ownership.xml · derivative · entry 7

Brenner Yael · CIK 0002064606 · VP Quality

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 0

Underlying: Ordinary Shares · 10,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 26, 2026.

F3 · derivative.exercise_date: Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant.

F3 · derivative.expiration_date: Options vested in four equal installments, with 25% vested on each of the four anniversaries of the date of grant.

F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-095332 · ownership.xml · nonDerivative · entry 6

Brenner Yael · CIK 0002064606 · VP Quality

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,266

F2 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 2,776 ordinary shares on net exercise of option to purchase 10,000 ordinary shares. The Company withheld 7,224 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on August 26, 2026 of $8.58, pursuant to the terms of the Company's 2011 Share Award Plan.

F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 26, 2026.

SEC source: 0001213900-26-095332 · ownership.xml · nonDerivative · entry 5

Brenner Yael · CIK 0002064606 · VP Quality

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,266

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 26, 2026.

SEC source: 0001213900-26-095332 · ownership.xml · nonDerivative · entry 4

Brenner Yael · CIK 0002064606 · VP Quality

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,266

F2 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 2,776 ordinary shares on net exercise of option to purchase 10,000 ordinary shares. The Company withheld 7,224 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on August 26, 2026 of $8.58, pursuant to the terms of the Company's 2011 Share Award Plan.

F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 26, 2026.

SEC source: 0001213900-26-095332 · ownership.xml · nonDerivative · entry 3

Brenner Yael · CIK 0002064606 · VP Quality

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,266

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 26, 2026.

SEC source: 0001213900-26-095332 · ownership.xml · nonDerivative · entry 2

Brenner Yael · CIK 0002064606 · VP Quality

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,266

F2 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 2,776 ordinary shares on net exercise of option to purchase 10,000 ordinary shares. The Company withheld 7,224 ordinary shares underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on August 26, 2026 of $8.58, pursuant to the terms of the Company's 2011 Share Award Plan.

F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 26, 2026.

SEC source: 0001213900-26-095332 · ownership.xml · nonDerivative · entry 1

Brenner Yael · CIK 0002064606 · VP Quality

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,266

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: All exercise and sale prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 26, 2026.

SEC source: 0001213900-26-085898 · ownership.xml · derivative · entry 1

RECANATI LEON · CIK 0000919590 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 30,000

Underlying: Ordinary Shares · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.

F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-085896 · ownership.xml · derivative · entry 1

ITSHAYEK ASSAF · CIK 0001481487 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 30,000

Underlying: Ordinary Shares · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.

F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-085901 · ownership.xml · derivative · entry 1

DAVIDI ISHAY · CIK 0001426753 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 30,000

Underlying: Ordinary Shares · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.

F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-085900 · ownership.xml · derivative · entry 1

Goldwasser Karnit · CIK 0002071721 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 30,000

Underlying: Ordinary Shares · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.

F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-085894 · ownership.xml · derivative · entry 1

Botzer Uri · CIK 0002128353 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 30,000

Underlying: Ordinary Shares · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.

F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-085902 · ownership.xml · derivative · entry 1

Asher-Topilsky Lilach · CIK 0002128355 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 30,000

Underlying: Ordinary Shares · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.

F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-085897 · ownership.xml · derivative · entry 1

Dekel Benjamin · CIK 0002077142 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 30,000

Underlying: Ordinary Shares · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.

F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-085899 · ownership.xml · derivative · entry 1

Tsur David · CIK 0002069828 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 30,000

Underlying: Ordinary Shares · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.

F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-085895 · ownership.xml · derivative · entry 1

Payorski Lilach · CIK 0002007989 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 30,000

Underlying: Ordinary Shares · 30,000 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.

F2 · derivative.exercise_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F2 · derivative.expiration_date: The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

F3 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 16

RECANATI LEON · CIK 0000919590 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 7,500

Underlying: Ordinary Shares · 7,500 shares

Expires 2029-06-22

F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026.

F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.

F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 15

RECANATI LEON · CIK 0000919590 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 7,500

Underlying: Ordinary Shares · 7,500 shares

Expires 2029-06-22

F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026.

F2 · derivative.exercise_price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.

F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.

F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 14

RECANATI LEON · CIK 0000919590 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 7,500

Underlying: Ordinary Shares · 7,500 shares

Expires 2029-06-22

F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026.

F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.

F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 13

RECANATI LEON · CIK 0000919590 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 7,500

Underlying: Ordinary Shares · 7,500 shares

Expires 2029-06-22

F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026.

F2 · derivative.exercise_price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.

F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.

F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 12

RECANATI LEON · CIK 0000919590 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 7,500

Underlying: Ordinary Shares · 7,500 shares

Expires 2029-06-22

F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026.

F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.

F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 11

RECANATI LEON · CIK 0000919590 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 7,500

Underlying: Ordinary Shares · 7,500 shares

Expires 2029-06-22

F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026.

F2 · derivative.exercise_price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.

F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.

F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 10

RECANATI LEON · CIK 0000919590 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 6,625

Underlying: Ordinary Shares · 6,625 shares

Expires 2026-09-25

F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026.

F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.

F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 9

RECANATI LEON · CIK 0000919590 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 6,625

Underlying: Ordinary Shares · 6,625 shares

Expires 2026-09-25

F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026.

F2 · derivative.exercise_price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.

F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.

F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 8

RECANATI LEON · CIK 0000919590 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 7,500

Underlying: Ordinary Shares · 7,500 shares

Expires 2029-06-22

F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026.

F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.

F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.

SEC source: 0001213900-26-041929 · ownership.xml · derivative · entry 7

RECANATI LEON · CIK 0000919590 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trustee

Disclosed balance after: 7,500

Underlying: Ordinary Shares · 7,500 shares

Expires 2029-06-22

F1 · derivative.exercise_price: All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 6, 2026.

F2 · derivative.exercise_price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.

F2 · price: The exercise price of the options was adjusted pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.

F3 · derivative.exercise_date: Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

F4 · ownership.nature: Held by trustee under the Company's 2011 Share Award Plan.